HomeCompareCDBT vs PLD

CDBT vs PLD: Dividend Comparison 2026

CDBT yields 2000.00% · PLD yields 3.18%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 CDBT wins by $9939315152.03M in total portfolio value
10 years
CDBT
CDBT
● Live price
2000.00%
Share price
$0.10
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$9939315158.53M
Annual income
$9,049,252,674,478,578.00
Full CDBT calculator →
PLD
PLD
● Live price
3.18%
Share price
$128.78
Annual div
$4.10
5Y div CAGR
74.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$6.50M
Annual income
$5,256,436.18
Full PLD calculator →

Portfolio growth — CDBT vs PLD

📍 CDBT pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCDBTPLD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CDBT + PLD cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
CDBT pays
PLD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CDBT
Annual income on $10K today (after 15% tax)
$170,000.00/yr
After 10yr DRIP, annual income (after tax)
$7,691,864,773,306,791.00/yr
PLD
Annual income on $10K today (after 15% tax)
$270.62/yr
After 10yr DRIP, annual income (after tax)
$4,467,970.75/yr
At 15% tax rate, CDBT beats the other by $7,691,864,768,838,820.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CDBT + PLD for your $10,000?

CDBT: 50%PLD: 50%
100% PLD50/50100% CDBT
Portfolio after 10yr
$4969657582.52M
Annual income
$4,524,626,339,867,507.00/yr
Blended yield
91.05%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PLD right now

CDBT
No analyst data
Altman Z
-9.4
Piotroski
2/9
PLD
Analyst Ratings
25
Buy
16
Hold
1
Sell
Consensus: Buy
Price Target
$136.00
+5.6% upside vs current
Range: $119.00 — $155.00
Altman Z
1.9
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CDBT buys
0
PLD buys
0
No recent congressional trades found for CDBT or PLD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCDBTPLD
Forward yield2000.00%3.18%
Annual dividend / share$2.00$4.10
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%74.4%
Portfolio after 10y$9939315158.53M$6.50M
Annual income after 10y$9,049,252,674,478,578.00$5,256,436.18
Total dividends collected$9876141646.27M$6.37M
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: CDBT vs PLD ($10,000, DRIP)

YearCDBT PortfolioCDBT Income/yrPLD PortfolioPLD Income/yrGap
1← crossover$210,700$200,000.00$11,255$555.24+$199.4KCDBT
2$4,163,767$3,938,317.76$13,062$1,018.59+$4.15MCDBT
3$77,191,133$72,735,902.82$15,903$1,926.67+$77.18MCDBT
4$1,342,813,676$1,260,219,163.76$20,839$3,823.32+$1342.79MCDBT
5$21,925,333,121$20,488,522,486.99$30,464$8,166.08+$21925.30MCDBT
6$336,109,296,351$312,649,189,912.21$52,054$19,457.30+$336109.24MCDBT
7$4,838,913,266,619$4,479,276,319,522.88$109,886$54,188.93+$4838913.16MCDBT
8$65,446,276,951,058$60,268,639,755,775.59$304,030$186,451.18+$65446276.65MCDBT
9$831,834,097,245,644$761,806,580,908,011.90$1,166,125$840,813.32+$831834096.08MCDBT
10$9,939,315,158,531,418$9,049,252,674,478,578.00$6,504,190$5,256,436.18+$9939315152.03MCDBT

CDBT vs PLD: Complete Analysis 2026

CDBTStock

China Dasheng Biotechnology Company, together with its subsidiaries, engages in the production, marketing, and distribution of bacteria based products used as additives for livestock feed and crop cultivation in the People's Republic of China. It provides artificial microorganisms (AM) and high-efficiency microorganism (HM) based biological bacterium blends; and biological preservatives. The company offers AM/HM bacteria based additives for crops, including Bulgaria lactobacillus, beer microzyme, and dark red spirilla used to increase the beneficial microorganism colonies in soil; inhibit the reproduction of harmful fungi and putrefactive bacteria; and to improve nutrient absorption and reduce crop and livestock diseases. It also provides AM/HM bacteria based additives for livestock feed, which softens the livestock feed and restrain the growth and reproduction of pathogenic bacteria, as well as supplies beneficial nutriments, including organic acid, vitamins, enzyme, antibiotics, mycelium protein, and other growth-enhancing substances that balance the nutrients in the feed. In addition, the company offers FGW bacterial based preservatives that preserve animal specimens for scientific research; and preserve the freshness for agricultural produce. Further, it provides bacteria based fertilizer for application on plants, such as vegetable and fruit leaves. Additionally, China Dasheng Biotechnology Company engages in residential and commercial real estate investment. The company was formerly known as Max Nutrition, Inc. and changed its name to China Dasheng Biotechnology Company in March 2008. China Dasheng Biotechnology Company is based in Lanzhou, China.

Full CDBT Calculator →

PLDREIT

Prologis, Inc. is the global leader in logistics real estate with a focus on high-barrier, high-growth markets. As of December 31, 2020, the company owned or had investments in, on a wholly owned basis or through co-investment ventures, properties and development projects expected to total approximately 984 million square feet (91 million square meters) in 19 countries. Prologis leases modern logistics facilities to a diverse base of approximately 5,500 customers principally across two major categories: business-to-business and retail/online fulfillment.

Full PLD Calculator →
📬

Get this CDBT vs PLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CDBT vs SCHDCDBT vs JEPICDBT vs OCDBT vs KOCDBT vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.